Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carboplatin (paraplatin) (1 trial)
cyclophosphamide (cytoxan) (2 trials)
docetaxel (taxotere) (2 trials)
doxorubicin (Doxil) (1 trial)
epirubicin (ellence) (2 trials)
etoposide (vepesid) (1 trial)
Filgrastim (neupogen) (1 trial)
fluorouracil (efudex) (2 trials)
paclitaxel (taxol) (1 trial)
pertuzumab (perjeta) (1 trial)
sargramostim (leukine) (1 trial)
trastuzumab (herceptin) (1 trial)
capecitabine (xeloda) (2 trials)
exemestane (aromasin) (1 trial)
galunisertib (1 trial)
letrozole (femara) (1 trial)
ly3200882 (1 trial)
tamoxifen (nolvadex) (1 trial)
vinorelbine (navelbine) (1 trial)
Breast Neoplasms (Phase 4)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Trials (7 total)
Trial APIs (19 total)